MX362495B - Un metodo para la seleccion de agentes que afectan los trastornos de motilidad intestinal y el dolor. - Google Patents

Un metodo para la seleccion de agentes que afectan los trastornos de motilidad intestinal y el dolor.

Info

Publication number
MX362495B
MX362495B MX2015002792A MX2015002792A MX362495B MX 362495 B MX362495 B MX 362495B MX 2015002792 A MX2015002792 A MX 2015002792A MX 2015002792 A MX2015002792 A MX 2015002792A MX 362495 B MX362495 B MX 362495B
Authority
MX
Mexico
Prior art keywords
intestinal motility
agents
selection
treatment
motility disorders
Prior art date
Application number
MX2015002792A
Other languages
English (en)
Spanish (es)
Other versions
MX2015002792A (es
Inventor
Connolly Eamonn
Kunze Wolfgang
Bienenstock John
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49115523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX362495(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of MX2015002792A publication Critical patent/MX2015002792A/es
Publication of MX362495B publication Critical patent/MX362495B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/10—Segmentation; Edge detection
    • G06T7/13—Edge detection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30092—Stomach; Gastric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Quality & Reliability (AREA)
MX2015002792A 2012-09-03 2013-09-03 Un metodo para la seleccion de agentes que afectan los trastornos de motilidad intestinal y el dolor. MX362495B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261696277P 2012-09-03 2012-09-03
PCT/EP2013/068202 WO2014033330A1 (en) 2012-09-03 2013-09-03 A method for selection of agents influencing intestinal motility disorders and pain

Publications (2)

Publication Number Publication Date
MX2015002792A MX2015002792A (es) 2015-05-07
MX362495B true MX362495B (es) 2019-01-21

Family

ID=49115523

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015002792A MX362495B (es) 2012-09-03 2013-09-03 Un metodo para la seleccion de agentes que afectan los trastornos de motilidad intestinal y el dolor.
MX2018013097A MX2018013097A (es) 2012-09-03 2015-03-03 Un metodo para la seleccion de agentes que afectan los trastornos de motilidad intestinal y el dolor.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2018013097A MX2018013097A (es) 2012-09-03 2015-03-03 Un metodo para la seleccion de agentes que afectan los trastornos de motilidad intestinal y el dolor.

Country Status (27)

Country Link
US (5) US9555065B2 (enExample)
EP (2) EP3369808A1 (enExample)
JP (3) JP6259458B2 (enExample)
KR (1) KR102293438B1 (enExample)
CN (4) CN108904545A (enExample)
AU (1) AU2013308299B2 (enExample)
CA (2) CA3268968A1 (enExample)
CL (2) CL2015000490A1 (enExample)
CO (1) CO7350654A2 (enExample)
DK (1) DK2893045T3 (enExample)
ES (1) ES2681974T3 (enExample)
GE (1) GEP201706775B (enExample)
HK (1) HK1258778A1 (enExample)
HR (1) HRP20181033T1 (enExample)
IL (2) IL237397B (enExample)
IN (1) IN2015DN01572A (enExample)
LT (1) LT2893045T (enExample)
MX (2) MX362495B (enExample)
MY (2) MY195532A (enExample)
NZ (1) NZ705358A (enExample)
PH (1) PH12015500452B1 (enExample)
RU (1) RU2701348C2 (enExample)
SG (3) SG10201608055XA (enExample)
SI (1) SI2893045T1 (enExample)
UA (2) UA118339C2 (enExample)
WO (1) WO2014033330A1 (enExample)
ZA (1) ZA201501472B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013002667B1 (pt) 2010-08-04 2020-02-04 Thomas Julius Borody composições para transplante da flora intestinal e métodos para fazê-las e usá-las e dispositivos para administrá-las
CN108094541A (zh) * 2018-01-11 2018-06-01 黑龙江完达山林海液奶有限公司 一种具有保健益生功能的风味发酵乳及其制备方法
CN117487686A (zh) * 2018-07-24 2024-02-02 生命大地女神有限公司 选择和使用褪黑素支持细菌以减少婴儿绞痛
WO2020247568A1 (en) * 2019-06-05 2020-12-10 Avl Powertrain Engineering, Inc. Vehicle axle assembly
EP3980285A1 (en) 2019-06-05 2022-04-13 AVL Powertrain Engineering, Inc. Vehicle frame assembly and power supply tray
US12263752B2 (en) 2019-06-05 2025-04-01 Avl Mobility Technologies, Inc. Vehicle frame and power supply assembly and related systems and methods
CN110186922B (zh) * 2019-06-25 2021-07-23 西安交通大学医学院第一附属医院 一种监测结肠移行性复合运动的实验装置及方法
US11843097B2 (en) 2019-09-10 2023-12-12 Avl Powertrain Engineering, Inc. Power supply control systems and methods
CN112710823B (zh) * 2020-12-17 2024-03-29 中国科学院深圳先进技术研究院 一种肠移行性复合运动的离体检测系统及其应用
CN114342878B (zh) * 2022-01-10 2022-09-30 南京鼓楼医院 一种慢传输型便秘动物模型的建立方法
CN117384804A (zh) * 2023-12-12 2024-01-12 北京三元食品股份有限公司 格氏乳杆菌b1-26及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5438989A (en) * 1990-08-10 1995-08-08 Hochman; Darryl Solid tumor, cortical function, and nerve tissue imaging methods and device
TR200100361T2 (tr) * 1998-08-21 2001-06-21 Novartis Ag Yeni oral formülasyon
CZ200213A3 (cs) * 1999-07-06 2002-08-14 Enpharma L. P. Prostředky k regulaci motility zaľívací soustavy a přijímání potravy
DK1565547T4 (da) * 2002-06-28 2013-01-14 Biosearch S A Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
CN1663573B (zh) * 2004-03-04 2010-04-28 青岛东海药业有限公司 一种稳定安全的微生态制剂及其制备方法和用途
US20090233888A1 (en) * 2005-03-23 2009-09-17 Usc Stevens, University Of Southern California Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
JP5036020B2 (ja) * 2005-11-30 2012-09-26 雪印メグミルク株式会社 腎周囲脂肪蓄積抑制剤
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
JP5019563B2 (ja) * 2006-06-16 2012-09-05 旭化成ケミカルズ株式会社 腸内細菌賦活剤
US9254275B2 (en) * 2007-09-17 2016-02-09 Cornell University Branched chain fatty acids for prevention or treatment of gastrointestinal disorders
SG177541A1 (en) * 2009-07-31 2012-02-28 Nestec Sa Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
US20110110905A1 (en) * 2009-11-06 2011-05-12 Ritchie Jennifer A Infant Colic Supplement
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
US20120034198A1 (en) * 2010-08-04 2012-02-09 Microbios, Inc. Carriers for storage and delivery of biologics
CN102304489B (zh) * 2011-09-23 2013-06-12 北京龙科方舟生物工程技术有限公司 一株罗伊氏乳杆菌及其应用

Also Published As

Publication number Publication date
AU2013308299A1 (en) 2015-03-26
EP3369808A1 (en) 2018-09-05
JP6259458B2 (ja) 2018-01-10
CN108904545A (zh) 2018-11-30
SG11201501297TA (en) 2015-03-30
PH12015500452A1 (en) 2015-04-20
SG10201608055XA (en) 2016-11-29
RU2015112102A (ru) 2016-10-20
MY195532A (en) 2023-01-31
US20170114422A1 (en) 2017-04-27
HK1258774A1 (zh) 2019-11-22
CN108753645A (zh) 2018-11-06
US20220306984A1 (en) 2022-09-29
AU2013308299B2 (en) 2019-04-18
IN2015DN01572A (enExample) 2015-07-03
CO7350654A2 (es) 2015-08-10
HK1211848A1 (en) 2016-06-03
GEP201706775B (en) 2017-11-27
RU2701348C2 (ru) 2019-09-26
JP2018090616A (ja) 2018-06-14
NZ705358A (en) 2018-09-28
JP2018029588A (ja) 2018-03-01
HRP20181033T1 (hr) 2018-08-24
US20190112676A1 (en) 2019-04-18
MY182358A (en) 2021-01-20
CA3268968A1 (en) 2025-11-29
PH12015500452B1 (en) 2023-01-20
KR20150048201A (ko) 2015-05-06
HK1258778A1 (zh) 2019-11-22
IL259652B (en) 2020-03-31
UA126374C2 (uk) 2022-09-28
CA2883440A1 (en) 2014-03-06
CN108753645B (zh) 2019-10-22
CN104918640A (zh) 2015-09-16
JP2015529329A (ja) 2015-10-05
ES2681974T3 (es) 2018-09-17
KR102293438B1 (ko) 2021-08-25
CL2015000490A1 (es) 2015-05-29
US9555065B2 (en) 2017-01-31
CN104918640B (zh) 2019-03-19
DK2893045T3 (en) 2018-07-30
LT2893045T (lt) 2018-07-25
ZA201501472B (en) 2016-06-29
US9816150B2 (en) 2017-11-14
IL259652A (en) 2018-07-31
SG10202101556WA (en) 2021-03-30
IL237397B (en) 2018-10-31
US20180023150A1 (en) 2018-01-25
MX2015002792A (es) 2015-05-07
JP6476328B2 (ja) 2019-02-27
US20150231186A1 (en) 2015-08-20
CL2017002826A1 (es) 2018-04-06
MX2018013097A (es) 2020-09-02
EP2893045B1 (en) 2018-05-16
UA118339C2 (uk) 2019-01-10
CN109966511A (zh) 2019-07-05
JP6322326B2 (ja) 2018-05-09
EP2893045A1 (en) 2015-07-15
US10174388B2 (en) 2019-01-08
IL237397A0 (en) 2015-04-30
SI2893045T1 (en) 2018-08-31
WO2014033330A1 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
MX362495B (es) Un metodo para la seleccion de agentes que afectan los trastornos de motilidad intestinal y el dolor.
MX2015011774A (es) Biomarcadores y metodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1.
MY194587A (en) Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration
MX394516B (es) Moléculas pequeñas contra cereblon para mejorar la función efectora de los linfocitos t.
BR112018070133A2 (pt) dispersão, uso desta e método para a inativação fotodinâmica de micro-organismos
MX2016005159A (es) Metodos de diagnostico y tratamiento de trastornos eosinofilicos.
CL2019003398A1 (es) Inhibidores pirazólicos de magl.
BR112012033078A2 (pt) dispositivo de acoplamento de ultrassom, kit de ultrassom terapêutico, método para realizar fisioterapia, método para aplicar energia de ultrassom, sistema, e, método para aplicar energia de ultrassom
CL2017000474A1 (es) N-alquilaril-5 oxyaryl-octahydri-cyclopenta [c] pyrrole modeladores allosteriscos negativos de nr2b
MX2021000295A (es) Compuestos inmunomoduladores dimericos contra mecanismos basados en cereblon.
CO2020000227A2 (es) Moduladores de nlrp3
MX2016002574A (es) Nuevos moduladores del homologo 6 (sez6) y metodos de uso.
CL2020001936A1 (es) Métodos para el tratamiento de la atrofía muscular espinal.
MX2019007894A (es) Composiciones y metodos para detectar el adn tumoral circulante.
UY31760A (es) Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de leucotrieno a4 hidrolasa
MX2022006862A (es) Inhibidores duales de magl y faah.
CO7141430A2 (es) Formulaciones vesiculares para uso en el tratamiento del dolor o movilidad reducida de una articulación
MX2017006075A (es) Biomarcadores para la progresion de enfermedades en melanoma.
BR112021015222A2 (pt) Métodos, sistemas e kits para tratamento de doença inflamatória de alvejamento de il18r1
MX2017003063A (es) Prueba de diagnostico basada en fragmento de rgma.
CY1122474T1 (el) Μεθοδος διαγνωσης νευραλγιας του τριδυμου
MX2021011263A (es) Uso de moduladores del receptor gabaa para el tratamiento del dolor.
GT201500124A (es) Forma sòlida de un derivado de dihidro-pirido-oxazina
MX2019015273A (es) Moduladores de alfa-sinucleinca.
MX2024002720A (es) Nanocuerpos anti-4-1bb.

Legal Events

Date Code Title Description
FG Grant or registration